Cargando…

Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Kataoka, Junro, Shiraha, Hidenori, Horiguchi, Shigeru, Sawahara, Hiroaki, Uchida, Daisuke, Nagahara, Teruya, Iwamuro, Masaya, Morimoto, Hiroki, Takeuchi, Yasuto, Kuwaki, Kenji, Onishi, Hideki, Nakamura, Shinichiro, Takaki, Akinobu, Nouso, Kazuhiro, Yagi, Takahito, Yamamoto, Kazuhide, Okada, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364867/ https://www.ncbi.nlm.nih.gov/pubmed/28184917 http://dx.doi.org/10.3892/or.2017.5419

Ejemplares similares

Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma
por: KATAOKA, JUNRO, et al.
Publicado: (2016)

Hepatic stellate cells promote upregulation of epithelial cell adhesion molecule and epithelial-mesenchymal transition in hepatic cancer cells
por: NAGAHARA, TERUYA, et al.
Publicado: (2015)

Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis
por: Nakanishi, Yutaka, et al.
Publicado: (2011)

A preliminary study for constructing a bioartificial liver device with induced pluripotent stem cell-derived hepatocytes
por: Iwamuro, Masaya, et al.
Publicado: (2012)

Study Protocol for a Trial: A Single-Arm, Open-Labeled Study Evaluating Transcatheter Arterial Embolization Plus Everolimus Combination Therapy for Patients With Liver Metastasis of Gastroenteropancreatic Neuroendocrine Tumors
por: Takeuchi, Yasuto, et al.
Publicado: (2022)

Twist expression promotes migration and invasion in hepatocellular carcinoma
por: Matsuo, Noriyuki, et al.
Publicado: (2009)

Laminin 511-E8 Fragment Offers Superior Adhesion Properties for Gastric Cancer Cells Compared with Full-Length Laminin 511
por: Iwamuro, Masaya, et al.
Publicado: (2022)

Management of Cirrhotic Ascites under the Add-on Administration of Tolvaptan
por: Adachi, Takuya, et al.
Publicado: (2021)

Gastric polyps' regression after potassium‐competitive acid blocker cessation
por: Iwamuro, Masaya, et al.
Publicado: (2022)

Oxidative stress-related markers as prognostic factors for patients with primary sclerosing cholangitis in Japan
por: Oyama, Atsushi, et al.
Publicado: (2023)

Contradictory Immune Response in Post Liver Transplantation Hepatitis B and C
por: Takaki, Akinobu, et al.
Publicado: (2014)

Safe and cost-effective control of post-transplantation recurrence of hepatitis B
por: Takaki, Akinobu, et al.
Publicado: (2015)

Which patients respond best to hepatitis B vaccination after a hepatitis B virus-related liver transplantation?
por: Takaki, Akinobu, et al.
Publicado: (2013)

The prediction of early progressive disease in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab
por: Takeuchi, Yasuto, et al.
Publicado: (2023)

A Huge Liver Cyst Manifesting Dyspnea and Edema
por: Nagao, Satoko, et al.
Publicado: (2019)

L-Carnitine Prevents Progression of Non-Alcoholic Steatohepatitis in a Mouse Model with Upregulation of Mitochondrial Pathway
por: Ishikawa, Hisashi, et al.
Publicado: (2014)

Serial Changes of Serum Growth Factor Levels and Liver Regeneration after Partial Hepatectomy in Healthy Humans
por: Matsumoto, Kazuyuki, et al.
Publicado: (2013)

Serum Glycan Markers for Evaluation of Disease Activity and Prediction of Clinical Course in Patients with Ulcerative Colitis
por: Miyahara, Koji, et al.
Publicado: (2013)

The Serum Oxidative/Anti-oxidative Stress Balance Becomes Dysregulated in Patients with Non-alcoholic Steatohepatitis Associated with Hepatocellular Carcinoma
por: Shimomura, Yasuyuki, et al.
Publicado: (2017)

Serum hepatitis B virus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxis
por: Yasunaka, Tetsuya, et al.
Publicado: (2011)

Hepatitis B virus core promoter mutations G1613A and C1653T are significantly associated with hepatocellular carcinoma in genotype C HBV-infected patients
por: Tatsukawa, Masashi, et al.
Publicado: (2011)

Enhancement of Programmed Death Ligand 2 on Hepatitis C Virus Infected Hepatocytes by Calcineurin Inhibitors
por: Koike, Kazuko, et al.
Publicado: (2015)

Safety and Efficacy of Small Bowel Examination by Capsule Endoscopy for Patients before Liver Transplantation
por: Seiji, Kawano, et al.
Publicado: (2017)

Corrigendum to “Safety and Efficacy of Small Bowel Examination by Capsule Endoscopy for Patients before Liver Transplantation”
por: Kawano, Seiji, et al.
Publicado: (2017)

A subclinical high tricuspid regurgitation pressure gradient independent of the mean pulmonary artery pressure is a risk factor for the survival after living donor liver transplantation
por: Saragai, Yosuke, et al.
Publicado: (2018)

Molecular Mechanisms to Control Post-Transplantation Hepatitis B Recurrence
por: Takaki, Akinobu, et al.
Publicado: (2015)

Human hepatocyte carcinogenesis
por: SHIRAHA, HIDENORI, et al.
Publicado: (2013)

Colonic manifestations of runt disease.
por: Singer, J. B., et al.
Publicado: (1966)

Pro-angiogenic cytokines for prediction of outcomes in patients with advanced hepatocellular carcinoma
por: Miyahara, K, et al.
Publicado: (2013)

IMMUNOLOGIC INCOMPETENCE OF IMMUNOLOGICALLY RUNTED ANIMALS
por: Blaese, R. Michael, et al.
Publicado: (1964)

STUDIES ON THE IMMUNOTHERAPY OF RUNT DISEASE IN RATS
por: Silvers, Willys K., et al.
Publicado: (1969)

STUDIES ON THE RUNTING SYNDROME IN NEWBORN MICE
por: Siskind, Gregory W., et al.
Publicado: (1959)

Predictive impact of polymorphism of PNPLA3 on HCC development after interferon therapy in Japanese patients with chronic hepatitis C
por: Moritou, Yuki, et al.
Publicado: (2013)

THE PRODUCTION OF RUNT DISEASE IN RATS THYMECTOMIZED AT BIRTH
por: Aisenberg, Alan C., et al.
Publicado: (1962)

Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylation
por: Hanafusa, Tadashi, et al.
Publicado: (2005)

AN ELECTRON MICROSCOPE STUDY OF LYMPHATIC TISSUE IN RUNT DISEASE
por: Weiss, Leon, et al.
Publicado: (1965)

Hairless is a cofactor for Runt-dependent transcriptional regulation
por: Walrad, Pegine B., et al.
Publicado: (2011)

Effect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the Nationwide Survey of Primary Liver Cancer in Japan
por: Nouso, K, et al.
Publicado: (2013)

Hepatic and Gastric Involvement in a Case of Systemic Sarcoidosis Presenting with Rupture of Esophageal Varices
por: Saito, Hiroaki, et al.
Publicado: (2017)

MATERNALLY INDUCED TRANSPLANTATION IMMUNITY, TOLERANCE, AND RUNT DISEASE IN RATS
por: Beer, Alan E., et al.
Publicado: (1972)

Cannot write session to /tmp/vufind_sessions/sess_8o5869ga3o18dpi9t0jlsq6uo8